A multi-institution study found that deletions of a certain tumor-suppressor gene in diffuse gliomas—the most common primary brain tumors—display distinct patterns, signify a poor prognosis in patients, and should be included in models predicting the clinical behavior of these tumors.
The Lilabean Foundation for Pediatric Brain Cancer Research raised $900,000 at its 13th Annual Lilabean Foundation Fall Ball, held on Saturday, November 2. Proceeds from the Fall Ball will directly fund groundbreaking research initiatives focused on discovering new treatments and improving survival rates for children fighting pediatric brain cancer.
